Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Enríquez Pérez, Julio"'
Autor:
Enríquez Pérez, Julio1 (AUTHOR) julio.enriquez_perez@med.lu.se, Kopecky, Jan1 (AUTHOR), Visse, Edward1,2 (AUTHOR), Darabi, Anna1 (AUTHOR), Siesjö, Peter1,2 (AUTHOR)
Publikováno v:
BMC Cancer. 1/3/2020, Vol. 20 Issue 1, p1-12. 12p. 2 Charts, 3 Graphs.
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Background Glioblastomas (GBM) are therapy-resistant tumors with a profoundly immunosuppressive tumor microenvironment. Chemotherapy has shown limited efficacy against GBM. Systemic delivery of chemotherapeutic drugs is hampered by the difficulty of
Autor:
Sandén, Emma, Enríquez Pérez, Julio, Visse, Edward, Kool, Marcel, Carén, Helena, Siesjö, Peter, Darabi, Anna, Sandén, Emma, Enríquez Pérez, Julio, Carén, Helena, Siesjö, Peter
Publikováno v:
Pediatric Blood & Cancer; Dec2016, Vol. 63 Issue 12, p2112-2122, 11p
Autor:
Sandén, Emma, Dyberg, Cecilia, Krona, Cecilia, Gallo-Oller, Gabriel, Olsen, Thale Kristin, Enríquez Pérez, Julio, Wickström, Malin, Estekizadeh, Atosa, Kool, Marcel, Visse, Edward, Ekström, Tomas J., Siesjö, Peter, Inge Johnsen, John, Darabi, Anna
Publikováno v:
Scientific Reports; 4/21/2017, p46366, 1p
Autor:
Governa V; Department of Clinical Sciences Lund, Section of Oncology, Lund University, Lund 221 85, Sweden., Talbot H; Department of Clinical Sciences Lund, Section of Oncology, Lund University, Lund 221 85, Sweden., Gonçalves de Oliveira K; Department of Clinical Sciences Lund, Section of Oncology, Lund University, Lund 221 85, Sweden., Cerezo-Magaña M; Department of Clinical Sciences Lund, Section of Oncology, Lund University, Lund 221 85, Sweden., Bång-Rudenstam A; Department of Clinical Sciences Lund, Section of Oncology, Lund University, Lund 221 85, Sweden., Johansson MC; Department of Clinical Sciences Lund, Section of Oncology, Lund University, Lund 221 85, Sweden., Månsson AS; Department of Clinical Sciences Lund, Section of Oncology, Lund University, Lund 221 85, Sweden., Forsberg-Nilsson K; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala 751 85, Sweden., Marko-Varga G; Clinical Protein Science and Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, Lund 221 85, Sweden.; Chemical Genomics Global Research Lab, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea.; First Department of Surgery, Tokyo Medical University, Tokyo 160-8402, Japan., Enríquez Pérez J; Department of Clinical Sciences Lund, Section of Neurosurgery, Lund University, Lund 221 85, Sweden., Darabi A; Department of Clinical Sciences Lund, Section of Neurosurgery, Lund University, Lund 221 85, Sweden., Malmström J; Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University, Lund 221 85, Sweden., Bengzon J; Department of Clinical Sciences Lund, Section of Neurosurgery, Lund University, Lund 221 85, Sweden.; Lund Stem Cell Center, Department of Clinical Sciences, Lund University, Lund 221 85, Sweden., Welinder C; Department of Clinical Sciences Lund, Section of Oncology, Lund University, Lund 221 85, Sweden., Belting M; Department of Clinical Sciences Lund, Section of Oncology, Lund University, Lund 221 85, Sweden; mattias.belting@med.lu.se.; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala 751 85, Sweden.; Department of Hematology, Oncology, and Radiophysics, Skåne University Hospital, Lund 221 85, Sweden.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Mar 01; Vol. 119 (9).
Autor:
Enríquez Pérez J; Glioma Immunotherapy Group, Division of Neurosurgery, Department of Clinical Sciences, Lund University, Lund, Sweden. julio.enriquez_perez@med.lu.se., Fritzell S; Glioma Immunotherapy Group, Division of Neurosurgery, Department of Clinical Sciences, Lund University, Lund, Sweden., Kopecky J; Glioma Immunotherapy Group, Division of Neurosurgery, Department of Clinical Sciences, Lund University, Lund, Sweden., Visse E; Glioma Immunotherapy Group, Division of Neurosurgery, Department of Clinical Sciences, Lund University, Lund, Sweden., Darabi A; Glioma Immunotherapy Group, Division of Neurosurgery, Department of Clinical Sciences, Lund University, Lund, Sweden., Siesjö P; Glioma Immunotherapy Group, Division of Neurosurgery, Department of Clinical Sciences, Lund University, Lund, Sweden.; Division of Neurosurgery, Department of Clinical Sciences, Skåne University Hospital, Lund, Sweden.
Publikováno v:
Scientific reports [Sci Rep] 2019 Apr 04; Vol. 9 (1), pp. 5632. Date of Electronic Publication: 2019 Apr 04.